H

Hoba Therapeutics

13 employees

Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
pharmaceutical industry
biotechnology
pain
Health Care
biologics
Neurophatic Pain
CNS
Pharmaceutical
CIPN
Hearing Loss

Date founded

2016

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

H

Hoba Therapeutics raised $2M on December 5, 2016

Investors: Novo Holdings and Borean Innovation

FAQ